Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-21

Clinical Trial Update: Study of GTx-024 on Muscle Wasting (Cachexia) Cancer. [Phase 2]

View source ↗

Summary

Phase 2 study of GTx-024 in cancer-related cachexia has completed and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GTx-024

Snippet

Sponsor: GTx | Conditions: Cachexia | Phase 2 | Status: COMPLETED | Results posted: 2013-02-21